Nitroxide pharmaceutical development for age-related degeneration and disease


Nitroxide small molecule agents are in development as preventative or therapeutic pharmaceutical drugs for age-related macular degeneration (AMD) and cardiovascular disease, which are two major diseases of aging. These aging diseases are associated with patient genetics, smoking, diet, oxidative stress, and chronic inflammation. Nitroxide drugs preventing… (More)
DOI: 10.3389/fgene.2015.00325


2 Figures and Tables